Cargando…

Hepatitis C RNA assay differences in results: Potential implications for shortened therapy and determination of Sustained Virologic Response

Approval of Ledipasvir/Sofosbuvir for the treatment of chronic hepatitis C (HCV) includes the truncation of therapy from 12 to 8 weeks in treatment naïve, non-cirrhotic patients with baseline HCV RNA levels <6 million IU/mL (6.8 log10 IU/mL). The aim of this study was to evaluate this clinical cu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cloherty, Gavin, Chevaliez, Stephane, Sarrazin, Christoph, Herman, Christine, Holzmayer, Vera, Dawson, George, Maasoumy, Benjamin, Vermehren, Johannes, Wedemeyer, Heiner, Feld, Jordan J., Pawlotsky, Jean-Michel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2016
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5071881/ https://www.ncbi.nlm.nih.gov/pubmed/27762283 http://dx.doi.org/10.1038/srep35410

Ejemplares similares

Hepatitis C Virus Serologic and Virologic Tests and Clinical Diagnosis of HCV-Related Liver Disease
por: Chevaliez, Stéphane, et al.
Publicado: (2006)

Performance of Two HCV RNA Assays during Protease Inhibitor-Based Triple Therapy in Patients with Advanced Liver Fibrosis and Cirrhosis
por: Maasoumy, Benjamin, et al.
Publicado: (2014)

Multicenter Comparison Study of both Analytical and Clinical Performance across Four Roche Hepatitis C Virus RNA Assays Utilizing Different Platforms
por: Vermehren, Johannes, et al.
Publicado: (2017)

Interferons and Their Use in Persistent Viral Infections
por: Chevaliez, Stéphane, et al.
Publicado: (2009)

Commutability and concordance of four hepatitis B virus DNA assays in an international multicenter study
por: Maasoumy, Benjamin, et al.
Publicado: (2017)

Expanding access to SARS-CoV-2 IgG and IgM serologic testing using fingerstick whole blood, plasma, and rapid lateral flow assays
por: Anderson, Mark, et al.
Publicado: (2021)

Hepatitis B seroconversion revisited: new insights into the natural history of acute hepatitis B virus (HBV) infection from quantitative and highly sensitive assays and novel biomarkers
por: Kuhns, Mary C., et al.
Publicado: (2021)

Clinical and virological features of chronic hepatitis B in the French national surveillance program, 2008–2012: A cross-sectional study
por: Chevaliez, Stéphane, et al.
Publicado: (2022)

HBcrAg Levels Are Associated With Virological Response to Treatment With Interferon in Patients With Hepatitis Delta
por: Sandmann, Lisa, et al.
Publicado: (2021)

Role of Serologic and Molecular Diagnostic Assays in Identification and Management of Hepatitis C Virus Infection
por: Cloherty, Gavin, et al.
Publicado: (2016)

Hepatitis C Virus (HCV) Genotype 1 Subtype Identification in New HCV Drug Development and Future Clinical Practice
por: Chevaliez, Stéphane, et al.
Publicado: (2009)

A novel standardized deep sequencing-based assay for hepatitis C virus genotype determination
por: Rodriguez, Christophe, et al.
Publicado: (2018)

Evaluation of hepatitis C virus antibody assay using dried blood spot samples
por: Holzmayer, Vera, et al.
Publicado: (2022)

Virologic Tools for HCV Drug Resistance Testing
por: Fourati, Slim, et al.
Publicado: (2015)

Molecular and serological characterization of hepatitis B vaccine breakthrough infections in serial samples from two plasma donors
por: Kuhns, Mary C., et al.
Publicado: (2019)

Utility of the new cobas HCV test for viral load monitoring during direct-acting antiviral therapy
por: Mücke, Marcus M., et al.
Publicado: (2019)

Identification of hepatitis B virus genotype I in Thailand
por: Holzmayer, Vera, et al.
Publicado: (2018)

Effects of renin–angiotensin inhibitors on renal function and the clinical course in patients with decompensated cirrhosis
por: Tergast, Tammo L., et al.
Publicado: (2023)

Approaches for simplified HCV diagnostic algorithms
por: Fourati, Slim, et al.
Publicado: (2018)

ARCHITECT HIV Combo Ag/Ab and RealTime HIV-1 Assays Detect Diverse HIV Strains in Clinical Specimens
por: Rodgers, Mary A., et al.
Publicado: (2018)

Alinity m, a Random-Access System, for Hepatitis B Virus DNA Quantification in Plasma and Whole Blood Collected on Dried Blood Spots
por: Ortonne, Valérie, et al.
Publicado: (2022)

More DNA and RNA of HBV SP1 splice variants are detected in genotypes B and C at low viral replication
por: Luk, Ka-Cheung, et al.
Publicado: (2021)

Clinical and Virological Aspects of HBV Reactivation: A Focus on Acute Liver Failure
por: Anastasiou, Olympia E., et al.
Publicado: (2019)

Diagnosis and Monitoring of Hepatitis B Virus Infection Using the Cobas(®) HBV Test for Use on the Cobas(®) 4800 System
por: Ortonne, Valérie, et al.
Publicado: (2021)

Poor clinical and virological outcome of nucleos(t)ide analogue monotherapy in HBV/HDV co-infected patients
por: Scheller, Laura, et al.
Publicado: (2021)

Molecular and Serological Characterization of Hepatitis B Virus (HBV)-Positive Samples with Very Low or Undetectable Levels of HBV Surface Antigen
por: Kuhns, Mary C., et al.
Publicado: (2021)

Detection of SARS-CoV-2 antibodies after confirmed Omicron BA.1 and presumed BA.4/5 infections using Abbott ARCHITECT and Panbio assays
por: Boler, Michael, et al.
Publicado: (2023)

Pilot Study Using Machine Learning to Identify Immune Profiles for the Prediction of Early Virological Relapse After Stopping Nucleos(t)ide Analogues in HBeAg‐Negative CHB
por: Wübbolding, Maximilian, et al.
Publicado: (2020)

New hepatitis C therapies in clinical development
por: Vermehren, Johannes, et al.
Publicado: (2011)

Evaluation of Sustained Virologic Response as a Relevant Surrogate Endpoint for Long-term Outcomes of Hepatitis C Virus Infection
por: Krassenburg, Lisette A P, et al.
Publicado: (2020)

Reaching the Unreachable: Strategies for HCV Eradication in Patients With Refractory Opioid Addiction—A Real-world Experience
por: Sandmann, Lisa, et al.
Publicado: (2021)

Persistent Control of Hepatitis B Virus and Hepatitis Delta Virus Infection Following REP 2139‐Ca and Pegylated Interferon Therapy in Chronic Hepatitis B Virus/Hepatitis Delta Virus Coinfection
por: Bazinet, Michel, et al.
Publicado: (2020)

Plasma Interferon-Gamma-Inducible Protein-10 Levels Are Associated with Early, but Not Sustained Virological Response during Treatment of Acute or Early Chronic HCV Infection
por: Feld, Jordan J., et al.
Publicado: (2013)

Nosocomial infections in female compared with male patients with decompensated liver cirrhosis
por: Griemsmann, Marie, et al.
Publicado: (2022)

Performance of 22 Rapid Lateral Flow Tests for SARS-CoV-2 Antigen Detection and Influence of “Variants of Concern”: Implications for Clinical Use
por: Gourgeon, Aurélie, et al.
Publicado: (2022)

High Sustained Virologic Response Rates of Glecaprevir/Pibrentasvir in Patients With Dosing Interruption or Suboptimal Adherence
por: Zamor, Philippe J., et al.
Publicado: (2021)

Treatment Status of Hepatocellular Carcinoma Does Not Influence Rates of Sustained Virologic Response: An HCV‐TARGET Analysis
por: Radhakrishnan, Kavita, et al.
Publicado: (2019)

Daclatasvir plus sofosbuvir, with or without ribavirin, achieved high sustained virological response rates in patients with HCV infection and advanced liver disease in a real-world cohort
por: Welzel, Tania M, et al.
Publicado: (2016)

New markers for diagnosis and management of chronic hepatitis C virus infection
por: Chevaliez, Stephane
Publicado: (2013)

Durability of Sustained Virologic Response in Chronic Hepatitis C
por: Uyanikoglu, Ahmet, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_583go8k35t0ioscapadri75vd3